Propranolol-hydrochlorothiazide combination in essential hypertension

Area of Science:

• Cardiology
• Pharmacology

Background:

• Essential hypertension is a prevalent cardiovascular condition requiring effective management.
• Combination therapy is often considered for hypertension when monotherapy is insufficient.

Purpose of the Study:

• To compare the efficacy and safety of a fixed-dose combination tablet of propranolol and hydrochlorothiazide against its individual components for treating mild to moderate essential hypertension.

Main Methods:

• A 12-week single-blind dose-finding study followed by a 10-week double-blind parallel treatment study.
• Patients received either the combination tablet, propranolol alone, or hydrochlorothiazide alone.
• Blood pressure changes were monitored throughout the study periods.

Main Results:

• The combination tablet significantly reduced both systolic and diastolic blood pressure more effectively than either component alone.
• Mean increases in blood pressure were substantially lower with the combination therapy at study endpoint.
• No significant differences in new patient complaints were observed between treatment groups, indicating similar safety profiles.

Conclusions:

• The propranolol-hydrochlorothiazide combination tablet is a safe and more effective treatment option for essential hypertension compared to monotherapy with either agent at equivalent doses.